Academic Content and Language Evaluation of This Article
CrossCheck and Google Search of This Article
Academic Rules and Norms of This Article
Citation of this article
Corresponding Author of This Article
Research Domain of This Article
Article-Type of This Article
Open-Access Policy of This Article
Times Cited Counts in Google of This Article
Number of Hits and Downloads for This Article
- Total Article Views (18012)
All Articles published online
|
Featured Article
|
Publishing Process of This Article
|
Aug 28, 2016 (publication date) through Nov 23, 2024
Times Cited of This Article
Journal Information of This Article
Publication Name
World Journal of Gastroenterology
ISSN
1007-9327
Publisher of This Article
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
| For: | Mikolasevic I, Orlic L, Franjic N, Hauser G, Stimac D, Milic S. Transient elastography (FibroScan®) with controlled attenuation parameter in the assessment of liver steatosis and fibrosis in patients with nonalcoholic fatty liver disease - Where do we stand? World J Gastroenterol 2016; 22(32): 7236-7251 [PMID: 27621571 DOI: 10.3748/wjg.v22.i32.7236] |
|---|---|
| URL: | https://www.wjgnet.com/1948-5204/full/v22/i32/7236.htm |
| Number | Citing Articles |
| 1 |
Ahmed Swelam, René Adam, Lelde Lauka, Luiza Basilio Rodrigues, Sherif Elgarf, Mylène Sebagh, Nicolas Golse, Antonio Sa Cunha, Daniel Cherqui, Denis Castaing, Marc‐Antoine Allard. A Model to Predict Significant Macrosteatosis in Hepatic Grafts. World Journal of Surgery 2020; 44(4): 1270 doi: 10.1007/s00268-019-05330-2
|
| 2 |
Ivana Mikolasevic, Goran Hauser, Maja Mijic, Viktor Domislovic, Delfa Radic-Kristo, Zeljko Krznaric, Melanija Razov-Radas, Tajana Pavic, Marija Matasin, Tajana Filipec Kanizaj, Kevork Peltekian. Assessment of Steatosis and Fibrosis in Liver Transplant Recipients Using Controlled Attenuation Parameter and Liver Stiffness Measurements. Canadian Journal of Gastroenterology and Hepatology 2021; 2021: 1 doi: 10.1155/2021/6657047
|
| 3 |
Cátia Arieira, Sara Monteiro, Sofia Xavier, Francisca Dias de Castro, Joana Magalhães, Carla Marinho, Rui Pinto, Washington Costa, José Pinto Correia, José Cotter. Transient elastography: should XL probe be used in all overweight patients?. Scandinavian Journal of Gastroenterology 2019; 54(8): 1022 doi: 10.1080/00365521.2019.1644367
|
| 4 |
Sihem Berdja, Lynda Boudarene, Leila Smail, Samia Neggazi, Saliha Boumaza, Abdelhamid Sahraoui, El-mehdi Haffaf, Ghouti Kacimi, Souhila Aouichat Bouguerra, Fatima Martel. Scolymus hispanicus (Golden Thistle) Ameliorates Hepatic Steatosis and Metabolic Syndrome by Reducing Lipid Accumulation, Oxidative Stress, and Inflammation in Rats under Hyperfatty Diet. Evidence-Based Complementary and Alternative Medicine 2021; 2021: 1 doi: 10.1155/2021/5588382
|
| 5 |
Lea Ladegaard Grønkjær, Charlotte Wernberg, Mette Munk Lauridsen. Non-alcoholic fatty liver disease: the role of the nurse. Gastrointestinal Nursing 2020; 18(Sup6): S15 doi: 10.12968/gasn.2020.18.Sup6.S15
|
| 6 |
Bertrand Cariou, Christopher D. Byrne, Rohit Loomba, Arun J. Sanyal. Nonalcoholic fatty liver disease as a metabolic disease in humans: A literature review. Diabetes, Obesity and Metabolism 2021; 23(5): 1069 doi: 10.1111/dom.14322
|
| 7 |
Andre Fialho, Andrea Fialho, Bruno Ribeiro, Miguel Malespin, Silvio De Melo, Ron Schey, Peter Ghali. Association Between Helicobacter pylori and Steatosis Severity on Transient Elastography . Cureus 2023; doi: 10.7759/cureus.34042
|
| 8 |
Bianca Senger Vasconcelos Barros, Fernanda Cruz Monteiro, Carlos Terra, Marilia Brito Gomes. Prevalence of non-alcoholic fatty liver disease and its associated factors in individuals with type 1 diabetes: a cross-sectional study in a tertiary care center in Brazil. Diabetology & Metabolic Syndrome 2021; 13(1) doi: 10.1186/s13098-021-00649-0
|
| 9 |
Lili Niu, Philipp E Geyer, Nicolai J Wewer Albrechtsen, Lise L Gluud, Alberto Santos, Sophia Doll, Peter V Treit, Jens J Holst, Filip K Knop, Tina Vilsbøll, Anders Junker, Stephan Sachs, Kerstin Stemmer, Timo D Müller, Matthias H Tschöp, Susanna M Hofmann, Matthias Mann. Plasma proteome profiling discovers novel proteins associated with non‐alcoholic fatty liver disease. Molecular Systems Biology 2019; 15(3) doi: 10.15252/msb.20188793
|
| 10 |
Adele Taibbi, Salvatore Petta, Domenica Matranga, Giovanni Caruana, Roberto Cannella, Gabriele Busè, Vito Di Marco, Massimo Midiri, Tommaso Vincenzo Bartolotta. Liver stiffness quantification in biopsy-proven nonalcoholic fatty liver disease patients using shear wave elastography in comparison with transient elastography. Ultrasonography 2021; 40(3): 407 doi: 10.14366/usg.20147
|
| 11 |
Teodora Biciusca, Sorina Ionelia Stan, Mara Amalia Balteanu, Ramona Cioboata, Alice Elena Ghenea, Suzana Danoiu, Ana-Maria Bumbea, Viorel Biciusca. The Role of the Fatty Liver Index (FLI) in the Management of Non-Alcoholic Fatty Liver Disease: A Systematic Review. Diagnostics 2023; 13(21): 3316 doi: 10.3390/diagnostics13213316
|
| 12 |
Ying-Hsiu Lin, Yung-Liang Wan, Dar-In Tai, Jeng-Hwei Tseng, Chiao-Yin Wang, Yu-Wei Tsai, Yi-Ru Lin, Tu-Yung Chang, Po-Hsiang Tsui. Considerations of Ultrasound Scanning Approaches in Non-alcoholic Fatty Liver Disease Assessment through Acoustic Structure Quantification. Ultrasound in Medicine & Biology 2019; 45(8): 1955 doi: 10.1016/j.ultrasmedbio.2019.04.018
|
| 13 |
Valerio Nobili, Anna Alisi, Luca Valenti, Luca Miele, Ariel E. Feldstein, Naim Alkhouri. NAFLD in children: new genes, new diagnostic modalities and new drugs. Nature Reviews Gastroenterology & Hepatology 2019; 16(9): 517 doi: 10.1038/s41575-019-0169-z
|
| 14 |
Cosmas Rinaldi Adithya Lesmana, Yoppi Kencana, Ikhwan Rinaldi, Juferdy Kurniawan, Irsan Hasan, Andri Sanityoso Sulaiman, Rino Alvani Gani. Diagnostic Value of Neutrophil to Lymphocyte Ratio in Non-Alcoholic Fatty Liver Disease Evaluated Using Transient Elastography (TE) with Controlled Attenuated Parameter (CAP). Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2022; : 15 doi: 10.2147/DMSO.S330526
|
| 15 |
Monica Lupsor-Platon, Teodora Serban, Alexandra-Iulia Silion, Alexandru Tirpe, Mira Florea. Hepatocellular Carcinoma and Non-Alcoholic Fatty Liver Disease: A Step Forward for Better Evaluation Using Ultrasound Elastography. Cancers 2020; 12(10): 2778 doi: 10.3390/cancers12102778
|
| 16 |
Junghoan Park, Jeong Min Lee, Gunwoo Lee, Sun Kyung Jeon, Ijin Joo. Quantitative Evaluation of Hepatic Steatosis Using Advanced Imaging Techniques: Focusing on New Quantitative Ultrasound Techniques. Korean Journal of Radiology 2022; 23(1): 13 doi: 10.3348/kjr.2021.0112
|
| 17 |
Emily Truong, Mazen Noureddin. The Interplay Between Nonalcoholic Fatty Liver Disease and Kidney Disease. Clinics in Liver Disease 2022; 26(2): 213 doi: 10.1016/j.cld.2022.01.008
|
| 18 |
Zora Meyer, Nikolaus Haas, Richard Mühlberg, Annabell Braun, Markus Fischer, Guido Mandilaras. Transient liver elastography in the follow-up of Fontan patients: results of a nation wide survey in Germany. Frontiers in Pediatrics 2023; 11 doi: 10.3389/fped.2023.1194641
|
| 19 |
Winda P. Bastian, Irsan Hasan, C. Rinaldi A. Lesmana, Ikhwan Rinaldi, Rino A. Gani. Gut Microbiota Profiles in Nonalcoholic Fatty Liver Disease and Its Possible Impact on Disease Progression Evaluated with Transient Elastography: Lesson Learnt from 60 Cases. Case Reports in Gastroenterology 2019; 13(1): 125 doi: 10.1159/000498946
|
| 20 |
Haruka Hirono, Kazuhiko Watanabe, Katsuhiko Hasegawa, Shogo Ohkoshi. Practical Use of Transient Elastography in Screening for Nonalcoholic Steatohepatitis in a Japanese Population. Journal of Clinical and Translational Hepatology 2019; 7(2): 1 doi: 10.14218/JCTH.2018.00048
|
| 21 |
Lindsey C. Shipley, Page D. Axley, Ashwani K. Singal. Liver Fibrosis: A Clinical Update. EMJ Hepatology 2019; : 105 doi: 10.33590/emjhepatol/10313576
|
| 22 |
Qiang Zeng, Zhenya Song, Yi Zhao, Jianjun Wu, Liuhong Wang, Huiyi Ye, Yingwei Wang, Ting Wu, Sishu Yuan, Haojie Yuan. Controlled attenuation parameter by vibration‐controlled transient elastography for steatosis assessment in members of the public undergoing regular health checkups with reference to magnetic resonance imaging‐based proton density fat fraction. Hepatology Research 2020; 50(5): 578 doi: 10.1111/hepr.13481
|
| 23 |
Dieter Broering, Mohamed Shawkat, Ali Albenmousa, Faisal Abaalkhail, Saleh Alabbad, Waleed Al-Hamoudi, Saad Alghamdi, Saleh Alqahthani, Ahmad Jaafari, Roberto Troisi, Khalid Bzeizi, Frank JMF Dor. Validating controlled attenuation parameter in the assessment of hepatic steatosis in living liver donors. PLOS ONE 2021; 16(5): e0251487 doi: 10.1371/journal.pone.0251487
|
| 24 |
Fernando de Barros, Ana Beatriz Monteiro Fonseca. Bariatric surgery during the evolution of fatty liver–A randomized clinical trial comparing gastric bypass and sleeve gastrectomy based on transient elastography. Clinical Obesity 2020; 10(6) doi: 10.1111/cob.12393
|
| 25 |
Tarik A.A. Hassan, Ayman Kamal, Mona Kaddah, Karim Mostafa, Wael Omar. Assessment of hepatic steatosis before and after laparoscopic sleeve gastrectomy. The Egyptian Journal of Surgery 2023; 42(2): 543 doi: 10.4103/ejs.ejs_90_23
|
| 26 |
M. Vanessa Bullón-Vela, Itziar Abete, J. Alfredo Martínez, M. Angeles Zulet. Obesity. 2018; : 111 doi: 10.1016/B978-0-12-812504-5.00006-4
|
| 27 |
Jelte J. Schaapman, Maarten E. Tushuizen, Minneke J. Coenraad, Hildo J. Lamb. Multiparametric MRI in Patients With Nonalcoholic Fatty Liver Disease. Journal of Magnetic Resonance Imaging 2021; 53(6): 1623 doi: 10.1002/jmri.27292
|
| 28 |
Reyhaneh Darvish Damavandi, Farzad Shidfar, Mohammad Najafi, Leila Janani, Mohsen Masoodi, Maryam Akbari‐Fakhrabadi, Afsaneh Dehnad. Effect of Portulaca Oleracea (purslane) extract on liver enzymes, lipid profile, and glycemic status in nonalcoholic fatty liver disease: A randomized, double‐blind clinical trial. Phytotherapy Research 2021; 35(6): 3145 doi: 10.1002/ptr.6972
|
| 29 |
Bisher Sawaf, Adel Hajj Ali, Rola F. Jaafar, Mariam Kanso, Deborah Mukherji, Mohamad J. Khalife, Walid Faraj. Spectrum of liver diseases in patients referred for Fibroscan: A single center experience in the Middle East. Annals of Medicine and Surgery 2020; 57: 166 doi: 10.1016/j.amsu.2020.07.040
|
| 30 |
I G Bakulin, Yu G Sandler, E V Vinnitskayа, V A Keiyan, S V Rodionova, D L Rotin. Diabetes mellitus and nonalcoholic fatty liver disease: The verges of contingency. Terapevticheskii arkhiv 2017; 89(2): 59 doi: 10.17116/terarkh201789259-65
|
| 31 |
Maëna Le Corvec, Marwin A. Farrugia, Eric Nguyen-Khac, Jean-Marc Régimbeau, Abdennaceur Dharhri, Denis Chatelain, Litavan Khamphommala, Anne-Lise Gautier, Nathalie Le Berre, Sébastien Frey, Jean-Pierre Bronowicki, Laurent Brunaud, Chloé Maréchal, Marie-Cécile Blanchet, Vincent Frering, Jean Delwaide, Laurent Kohnen, Alexandre Haumann, Philippe Delvenne, Marine Sarfati-Lebreton, Hugues Tariel, Jérôme Bernard, Alexis Toullec, Jérôme Boursier, Pierre Bedossa, Philippe Gual, Rodolphe Anty, Antonio Iannelli. Blood-based MASH diagnostic in candidates for bariatric surgery using mid-infrared spectroscopy: a European multicenter prospective study. Scientific Reports 2024; 14(1) doi: 10.1038/s41598-024-72704-5
|
| 32 |
Antoine Moret, Jérome Boursier, Pauline Houssel Debry, Jérémie Riou, Anne Crouan, Marine Dubois, Sophie Michalak Provost, Christophe Aubé, Anita Paisant. Evaluation of the Hepatorenal B-Mode Ratio and the “Controlled Attenuation Parameter” for the Detection and Grading of Steatosis. Ultraschall in der Medizin - European Journal of Ultrasound 2022; 43(05): 479 doi: 10.1055/a-1233-2290
|
| 33 |
Adelaida Solomon, Mihai Octavian Negrea, Călin Remus Cipăian, Adrian Boicean, Romeo Mihaila, Cristina Rezi, Bianca Andreea Cristinescu, Cristian Stefan Berghea-Neamtu, Mirela Livia Popa, Minodora Teodoru, Oana Stoia, Bogdan Neamtu. Interactions between Metabolic Syndrome, MASLD, and Arterial Stiffening: A Single-Center Cross-Sectional Study. Healthcare 2023; 11(19): 2696 doi: 10.3390/healthcare11192696
|
| 34 |
Arthur Pearson, Paul‐Armand Dujardin, Louis d'Alteroche, Frédéric Patat, Béatrice Scotto, Fanny Dujardin, Cécile Bastard, Véronique Miette, Laurent Sandrin, Jean‐Pierre Remenieras. Vibration‐controlled transient elastography for noninvasive evaluation of liver steatosis. Medical Physics 2022; 49(3): 1507 doi: 10.1002/mp.15484
|
| 35 |
Elena N. Shirokova, Chavdar S. Pavlov, Anna D. Karaseva, Aliya M. Alieva, Alla V. Sedova, Vladimir T. Ivashkin. Elastography in the Diagnosis of Non-Alcoholic Fatty Liver Disease. Annals of the Russian academy of medical sciences 2019; 74(1): 5 doi: 10.15690/vramn1071
|
| 36 |
Madalina-Gabriela Taru, Lidia Neamti, Vlad Taru, Lucia Maria Procopciuc, Bogdan Procopet, Monica Lupsor-Platon. How to Identify Advanced Fibrosis in Adult Patients with Non-Alcoholic Fatty Liver Disease (NAFLD) and Non-Alcoholic Steatohepatitis (NASH) Using Ultrasound Elastography—A Review of the Literature and Proposed Multistep Approach. Diagnostics 2023; 13(4): 788 doi: 10.3390/diagnostics13040788
|
| 37 |
I. Mikolasevic, V. Lukenda Zanko, I. Jakopcic, V. Domislovic, A. Mijic, T. Stevanovic, B. Delija, T. Bokun, P. Dinjar Kujundzic, A. Ostojic, T. Filipec Kanizaj, I. Grgurevic, Z. Krznaric, D. Stimac, G. Targher. Prospective evaluation of non-alcoholic fatty liver disease by elastographic methods of liver steatosis and fibrosis; controlled attenuation parameter and liver stiffness measurements. Journal of Diabetes and its Complications 2020; 34(3): 107512 doi: 10.1016/j.jdiacomp.2019.107512
|
| 38 |
Afina Bestavashvili, Oleg Glazachev, Alexander Bestavashvili, Alexander Suvorov, Yong Zhang, Xinliang Zhang, Andrey Rozhkov, Natalia Kuznetsova, Chavdar Pavlov, Dmitriy Glushenkov, Philippe Kopylov. Intermittent Hypoxic-Hyperoxic Exposures Effects in Patients with Metabolic Syndrome: Correction of Cardiovascular and Metabolic Profile. Biomedicines 2022; 10(3): 566 doi: 10.3390/biomedicines10030566
|
| 39 |
Xinrong Zhang, Grace Lai-Hung Wong, Vincent Wai-Sun Wong. Application of transient elastography in nonalcoholic fatty liver disease. Clinical and Molecular Hepatology 2020; 26(2): 128 doi: 10.3350/cmh.2019.0001n
|
| 40 |
Eron G. Manusov, Vincent P. Diego, Marcio Almeida, David Ortiz, Joanne E. Curran, Jacob Galan, Ana C. Leandro, Sandra Laston, John Blangero, Sarah Williams-Blangero. Genotype-by-Environment Interactions in Nonalcoholic Fatty Liver Disease and Chronic Illness among Mexican Americans: The Role of Acculturation Stress. Genes 2024; 15(8): 1006 doi: 10.3390/genes15081006
|
| 41 |
Xinyu Yang, Xinxia Chang, Shengdi Wu, Xiaoyang Sun, Xiaopeng Zhu, Liu Wang, Yushan Xu, Xiuzhong Yao, Shengxiang Rao, Xiqi Hu, Mingfeng Xia, Hua Bian, Hongmei Yan, Xin Gao. Performance of liver stiffness measurements obtained with FibroScan is affected by glucose metabolism in patients with nonalcoholic fatty liver disease. Lipids in Health and Disease 2021; 20(1) doi: 10.1186/s12944-021-01453-5
|
| 42 |
Ying-Hsiu Lin, Yin-Yin Liao, Chih-Kuang Yeh, Kuen-Cheh Yang, Po-Hsiang Tsui. Ultrasound Entropy Imaging of Nonalcoholic Fatty Liver Disease: Association with Metabolic Syndrome. Entropy 2018; 20(12): 893 doi: 10.3390/e20120893
|
| 43 |
Sarunporn Kamolvisit, Supphamat Chirnaksorn, Hataikarn Nimitphong, Somnuek Sungkanuparph. Pioglitazone for the Treatment of Metabolic-Associated Fatty Liver Disease in People Living With HIV and Prediabetes. Cureus 2021; doi: 10.7759/cureus.19046
|
| 44 |
Duo-Duo Lv, You-Juan Wang, Meng-Lan Wang, En-Qiang Chen, Ya-Chao Tao, Dong-Mei Zhang, Hong Tang. Effect of silibinin capsules combined with lifestyle modification on hepatic steatosis in patients with chronic hepatitis B. Scientific Reports 2021; 11(1) doi: 10.1038/s41598-020-80709-z
|
| 45 |
Dan Lv, Zepu Wang, Cuiqiao Meng, Yan Li, Shuai Ji. A study of the relationship between serum asprosin levels and MAFLD in a population undergoing physical examination. Scientific Reports 2024; 14(1) doi: 10.1038/s41598-024-62124-w
|
| 46 |
Marek Frankowski, Jerzy Świerkot, Marek Gomułkiewicz, Lucyna Korman, Marta Skoczyńska, Aleksandra Starba. Usefulness of noninvasive diagnostic procedures for assessment of methotrexate hepatotoxicity in patients with rheumatoid arthritis. Rheumatology International 2022; 42(4): 631 doi: 10.1007/s00296-021-05059-z
|
| 47 |
Pauline Tortajada, Rodrigue Doamba, Luis Cano, Mohammed Ghallab, Marc Antoine Allard, Oriana Ciacio, Gabriella Pittau, Chady Salloum, Daniel Cherqui, René Adam, Antonio Sa Cunha, Daniel Azoulay, Alina Pascale, Eric Vibert, Nicolas Golse. Resectable and transplantable hepatocellular carcinoma: Integration of liver stiffness assessment in the decision-making algorithm. Surgery 2022; 172(6): 1704 doi: 10.1016/j.surg.2022.08.012
|
| 48 |
Yanal Alnimer, Touleen Alnimer, Kevork M. Peltekian. Prediction of Liver Steatosis and Fibrosis Based on Clinical Variables Using a Large National Survey Database. Canadian Journal of Gastroenterology and Hepatology 2023; 2023: 1 doi: 10.1155/2023/1791500
|
| 49 |
Mohammad Alizadeh, Mohammadreza Mohammad Hosseiniazar, Farkhondeh Alami, Somayyeh Bararnia Adabi. The effects of meal patterns on liver steatosis, fibrosis, and biochemical factors in patients with nonalcoholic fatty liver disease: a randomized controlled clinical trial. Journal of Diabetes & Metabolic Disorders 2024; 23(1): 987 doi: 10.1007/s40200-023-01375-2
|
| 50 |
Rishi Philip Mathew, Sudhakar Kundapur Venkatesh. Imaging of Hepatic Fibrosis. Current Gastroenterology Reports 2018; 20(10) doi: 10.1007/s11894-018-0652-7
|
| 51 |
Ivana Mikolasevic, Andela Lukic, Toni Juric, Mia Klapan, Petra Madzar, Nikola Krolo, Doris Kolovrat, Ivanka Jurica, Iva Kedmenec, Domagoj Kihas, Doris Ilovaca, Ivan Erstic, Vanda Haralovic, Danijel Cavlina, Ema Dejhalla, Danijela Erdeljac, Benjamin Vukalovic, Nadija Skenderevic, Sandra Milic. Non-alcoholic fatty liver disease and transient elastography. Exploration of Medicine 2020; 1(4): 205 doi: 10.37349/emed.2020.00014
|
| 52 |
Wolhwa Song, Sung Hwan Yoo, Jinsun Jang, Su Jung Baik, Byoung Kwon Lee, Hyun Woong Lee, Jong Suk Park. Association between Sarcopenic Obesity Status and Nonalcoholic Fatty Liver Disease and Fibrosis. Gut and Liver 2023; 17(1): 130 doi: 10.5009/gnl220041
|
| 53 |
Tilman Kühn, Tobias Nonnenmacher, Disorn Sookthai, Ruth Schübel, Daniel Antonio Quintana Pacheco, Oyunbileg von Stackelberg, Mirja E. Graf, Theron Johnson, Christopher L. Schlett, Romy Kirsten, Cornelia M. Ulrich, Rudolf Kaaks, Hans-Ulrich Kauczor, Johanna Nattenmüller. Anthropometric and blood parameters for the prediction of NAFLD among overweight and obese adults. BMC Gastroenterology 2018; 18(1) doi: 10.1186/s12876-018-0840-9
|
| 54 |
Elham Ehrampoush, Alireza Ghaemi, Saeed Osati, Maryam Maleki, Hadi Raeisi Shahraki, Behnam Honarvar, Maryam Bahmanyar, Reza Homayounfar. The Association Between Serum Vitamin D Level and Nonalcoholic Fatty Liver Disease. Hepatitis Monthly 2019; 19(9) doi: 10.5812/hepatmon.92992
|
| 55 |
Gabriela Handzlik, Michał Holecki, Joanna Kozaczka, Michał Kukla, Katarzyna Wyskida, Leszek Kędzierski, Krzysztof Pawlicki, Jan Duława. Evaluation of metformin therapy using controlled attenuation parameter and transient elastography in patients with non-alcoholic fatty liver disease. Pharmacological Reports 2019; 71(2): 183 doi: 10.1016/j.pharep.2018.10.013
|
| 56 |
Ivana Mikolasevic, Sandra Milic, Tajana Filipec‐Kanizaj. Fatty liver allografts are associated with primary graft non‐function and high mortality after transplantation. Liver International 2017; 37(8): 1113 doi: 10.1111/liv.13453
|
| 57 |
Antonella Mosca, Nadia Panera, Annalisa Crudele, Anna Alisi. Noninvasive diagnostic tools for pediatric NAFLD: where are we now?. Expert Review of Gastroenterology & Hepatology 2020; 14(11): 1035 doi: 10.1080/17474124.2020.1801413
|
| 58 |
Nora A. Alfadda, Ghadeer S. Aljuraiban, Hadeel M. Awwad, Mohammad S. Khaleel, Abdulrahman M. Almaghamsi, Suphia M. Sherbeeni, Adel N. Alqutub, Abdullah S. Aldosary, Assim A. Alfadda. Higher carbohydrate intake in relation to non-alcoholic fatty liver disease in patients with type 2 diabetes. Frontiers in Nutrition 2022; 9 doi: 10.3389/fnut.2022.996004
|
| 59 |
Ivana Mikolasevic, Goran Poropat, Tajana Filipec Kanizaj, Nadija Skenderevic, Marko Zelic, Marija Matasin, Luka Vranic, Andrea Kresovic, Goran Hauser, Geoffrey Williams. Association between Gastroesophageal Reflux Disease and Elastographic Parameters of Liver Steatosis and Fibrosis: Controlled Attenuation Parameter and Liver Stiffness Measurements. Canadian Journal of Gastroenterology and Hepatology 2021; 2021: 1 doi: 10.1155/2021/6670065
|
| 60 |
Mohammad Ariya, Farbod Koohpayeh, Alireza Ghaemi, Saeed Osati, Sayed Hossain Davoodi, Jalaledin Mirzay Razzaz, Gholamali Javedan, Elham Ehrampoush, Reza Homayounfar, Gianfranco D. Alpini. Assessment of the association between body composition and risk of non-alcoholic fatty liver. PLOS ONE 2021; 16(4): e0249223 doi: 10.1371/journal.pone.0249223
|
| 61 |
Anne Linde Mak, Jenny Lee, Anne-Marieke van Dijk, Yasaman Vali, Guruprasad P. Aithal, Jörn M. Schattenberg, Quentin M. Anstee, M. Julia Brosnan, Mohammad Hadi Zafarmand, Dewkoemar Ramsoekh, Stephen A. Harrison, Max Nieuwdorp, Patrick M. Bossuyt, Adriaan G. Holleboom. Systematic Review with Meta-Analysis: Diagnostic Accuracy of Pro-C3 for Hepatic Fibrosis in Patients with Non-Alcoholic Fatty Liver Disease. Biomedicines 2021; 9(12): 1920 doi: 10.3390/biomedicines9121920
|
| 62 |
Chavdar Savov Pavlov, Taisiya Alekseevna Turankova, Dar'ya Leonidovna Varganova. LIPOSOMAL TECHNOLOGIES FOR SILYBIN DELIVERY TO THE LIVER IN PATIENTS WITH NON-ALCOHOLIC FATTY LIVER DISEASE. Ulyanovsk Medico-biological Journal 2023; (1): 50 doi: 10.34014/2227-1848-2023-1-50-62
|
| 63 |
Terence N Moyana. Metabolic dysfunction-associated steatotic liver disease: The question of long-term high-normal alanine aminotransferase as a screening test. World Journal of Gastroenterology 2024; 30(42): 4576-4582 doi: 10.3748/wjg.v30.i42.4576
|
| 64 |
Eugenia Tsai, Tai-Ping Lee. Diagnosis and Evaluation of Nonalcoholic Fatty Liver Disease/Nonalcoholic Steatohepatitis, Including Noninvasive Biomarkers and Transient Elastography. Clinics in Liver Disease 2018; 22(1): 73 doi: 10.1016/j.cld.2017.08.004
|
| 65 |
Mazen Noureddin, Micaela M Wong, Tsuyoshi Todo, Shelly C Lu, Arun J Sanyal, Edward A Mena. Fatty liver in hepatitis C patients post-sustained virological response with direct-acting antivirals. World Journal of Gastroenterology 2018; 24(11): 1269-1277 doi: 10.3748/wjg.v24.i11.1269
|
| 66 |
Paul A. Gomez, Kelly M. Zucker, Jean Chang, Michael W. Rowley, Anil B. Seetharam. Severe pretreatment hepatic steatosis influences response to direct acting antiviral therapy for chronic hepatitis C in a real world setting. Clinics and Research in Hepatology and Gastroenterology 2020; 44(2): e35 doi: 10.1016/j.clinre.2019.05.004
|
| 67 |
Aki Juhani Käräjämäki, Janne Hukkanen, Olavi Ukkola. The association of non-alcoholic fatty liver disease and atrial fibrillation: a review. Annals of Medicine 2018; 50(5): 371 doi: 10.1080/07853890.2018.1492147
|
| 68 |
Zobair M. Younossi, Mazen Noureddin, David Bernstein, Paul Kwo, Mark Russo, Mitchell L. Shiffman, Ziad Younes, Manal Abdelmalek. Role of Noninvasive Tests in Clinical Gastroenterology Practices to Identify Patients With Nonalcoholic Steatohepatitis at High Risk of Adverse Outcomes: Expert Panel Recommendations. American Journal of Gastroenterology 2021; 116(2): 254 doi: 10.14309/ajg.0000000000001054
|
| 69 |
Dong Hyeon Lee, Se Un Sung, Yun Kyu Lee, Ik Hyeon Lim, Heejoon Jang, Sae Kyoung Joo, Jeong Hwan Park, Mee Soo Chang, Young Ho So, Won Kim. A sequential approach using the age‐adjusted fibrosis‐4 index and vibration‐controlled transient elastography to detect advanced fibrosis in Korean patients with non‐alcoholic fatty liver disease. Alimentary Pharmacology & Therapeutics 2022; 55(8): 994 doi: 10.1111/apt.16766
|
| 70 |
Benjamin M. MacCurtain, Ned P. Quirke, Stephen D. Thorpe, Tom K. Gallagher. Pancreatic Ductal Adenocarcinoma: Relating Biomechanics and Prognosis. Journal of Clinical Medicine 2021; 10(12): 2711 doi: 10.3390/jcm10122711
|
| 71 |
Kenji Tsunoda, Naruki Kitano, Yuko Kai, Takashi Jindo, Ken Uchida, Takashi Arao. Dose–response relationships of accelerometer‐measured sedentary behaviour and physical activity with non‐alcoholic fatty liver disease. Alimentary Pharmacology & Therapeutics 2021; 54(10): 1330 doi: 10.1111/apt.16631
|
| 72 |
Hong-Bae Kim, Yong-Jae Lee. Association of resting heart rate with nonalcoholic fatty liver disease in postmenopausal women. Medicine 2020; 99(14): e19529 doi: 10.1097/MD.0000000000019529
|
| 73 |
Ralf Weiskirchen, Frank Tacke. The Role of Radiologic Modalities in Diagnosing Nonalcoholic Steatohepatitis (NASH) and Fibrosis. Current Hepatology Reports 2018; 17(4): 324 doi: 10.1007/s11901-018-0421-y
|
| 74 |
Abdallah A. Elsawy, Hossam Hodeib, Ahmed F. Selim, Mohamed E. Sarhan, Ahmed A. Elhadidy, Heba M. Sameir, Amal Selim, Mohamed A. Tawfik. The possible association between blood level of free cholesterol and the severity of steatosis in patients with nonalcoholic fatty liver disease. Tanta Medical Journal 2023; 51(1): 34 doi: 10.4103/tmj.tmj_23_22
|
| 75 |
Jianghua Zhou, Feng Zhou, Wenxin Wang, Xiao‐Jing Zhang, Yan‐Xiao Ji, Peng Zhang, Zhi‐Gang She, Lihua Zhu, Jingjing Cai, Hongliang Li. Epidemiological Features of NAFLD From 1999 to 2018 in China. Hepatology 2020; 71(5): 1851 doi: 10.1002/hep.31150
|
| 76 |
Weon Jang, Ji Soo Song. Non-Invasive Imaging Methods to Evaluate Non-Alcoholic Fatty Liver Disease with Fat Quantification: A Review. Diagnostics 2023; 13(11): 1852 doi: 10.3390/diagnostics13111852
|
| 77 |
Eron Grant Manusov, Vincent P. Diego, Khalid Sheikh, Sandra Laston, John Blangero, Sarah Williams-Blangero. Non-alcoholic Fatty Liver Disease and Depression: Evidence for Genotype × Environment Interaction in Mexican Americans. Frontiers in Psychiatry 2022; 13 doi: 10.3389/fpsyt.2022.936052
|
| 78 |
Madalina-Gabriela Taru, Monica Lupsor-Platon. Exploring Opportunities to Enhance the Screening and Surveillance of Hepatocellular Carcinoma in Non-Alcoholic Fatty Liver Disease (NAFLD) through Risk Stratification Algorithms Incorporating Ultrasound Elastography. Cancers 2023; 15(16): 4097 doi: 10.3390/cancers15164097
|
| 79 |
Therese Adrian, Ida M H Sørensen, Filip K Knop, Susanne Bro, Ellen L F Ballegaard, Børge G Nordestgaard, Andreas Fuchs, Klaus F Kofoed, Jørgen T Kühl, Per E Sigvardsen, Mads Hornum, Bo Feldt-Rasmussen. Prevalence of non-alcoholic fatty liver disease in patients with chronic kidney disease: a cross-sectional study. Nephrology Dialysis Transplantation 2022; 37(10): 1927 doi: 10.1093/ndt/gfab266
|
| 80 |
Ozge Yetginoglu, Dilek Barutcu Atas, Yusuf Yilmaz, Arzu Velioglu, Hakki Arikan, Fatma Alibaz-Oner, Haner Direskeneli, Serhan Tuglular, Ebru Asicioglu. Fibroscan detection of fatty liver and liver fibrosis in patients with systemic lupus erythematosus. Lupus 2022; 31(6): 723 doi: 10.1177/09612033221094708
|
| 81 |
Chiara Pisetta, Claudia Chillè, Giovanni Pelizzari, Marie Graciella Pigozzi, Massimo Salvetti, Anna Paini, Maria Lorenza Muiesan, Carolina De Ciuceis, Chiara Ricci, Damiano Rizzoni. Evaluation of Cardiovascular Risk in Patient with Primary Non-alcoholic Fatty Liver Disease. High Blood Pressure & Cardiovascular Prevention 2020; 27(4): 321 doi: 10.1007/s40292-020-00389-8
|
| 82 |
Monica Lupsor-Platon. Non-Alcoholic Fatty Liver Disease - Molecular Bases, Prevention and Treatment. 2018; doi: 10.5772/intechopen.71161
|
| 83 |
Tavitiya Sudjaritruk, Torsak Bunupuradah, Linda Aurpibul, Pope Kosalaraksa, Nia Kurniati, Jiratchaya Sophonphan, Panruethai Trinavarat, Pannee Visrutaratna, Jiraporn Srinakarin, Nataruks Chaijitraruch, Thanyawee Puthanakit, Wing-Kin Syn. Nonalcoholic fatty liver disease and hepatic fibrosis among perinatally HIV-monoinfected Asian adolescents receiving antiretroviral therapy. PLOS ONE 2019; 14(12): e0226375 doi: 10.1371/journal.pone.0226375
|
| 84 |
Yaw A Wiafe, Ijeoma C Anyitey-Kokor, Richmond A Nmai, Mary Afihene, Lewis R Roberts. Diagnostic Performance of Greyscale Ultrasound in Detecting Fatty Liver Disease in a Type 2 Diabetes Population Using FibroScan as the Reference Standard. Cureus 2023; doi: 10.7759/cureus.40756
|
| 85 |
Rasha M. Ghaleb, Doaa M. Mohamed, Zaki M. Zaki, Nadia F. El Ameen, Ahmed Hamed. Assessment of liver fibrosis by transient elastography and procollagen III amino terminal propeptide in rheumatoid arthritis patients treated with methotrexate. Egyptian Journal of Radiology and Nuclear Medicine 2024; 55(1) doi: 10.1186/s43055-024-01323-x
|
| 86 |
You-Wen Tan, Xing-Bei Zhou, Yun Ye, Cong He, Guo-Hong Ge. Diagnostic value of FIB-4, aspartate aminotransferase-to-platelet ratio index and liver stiffness measurement in hepatitis B virus-infected patients with persistently normal alanine aminotransferase. World Journal of Gastroenterology 2017; 23(31): 5746-5754 doi: 10.3748/wjg.v23.i31.5746
|
| 87 |
Duanghathai Pasanta, Khin Thandar Htun, Jie Pan, Montree Tungjai, Siriprapa Kaewjaeng, Hongjoo Kim, Jakrapong Kaewkhao, Suchart Kothan. Magnetic Resonance Spectroscopy of Hepatic Fat from Fundamental to Clinical Applications. Diagnostics 2021; 11(5): 842 doi: 10.3390/diagnostics11050842
|
| 88 |
Qichen Long, Fengming Luo, Binghui Li, Ziyang Li, Zhe Guo, Zhiyang Chen, Weimin Wu, Min Hu. Gut microbiota and metabolic biomarkers in metabolic dysfunction–associated steatotic liver disease. Hepatology Communications 2024; 8(3) doi: 10.1097/HC9.0000000000000310
|
| 89 |
Katharina Staufer, Mirko Dengler, Heidemarie Huber, Rodrig Marculescu, Rudolf Stauber, Carolin Lackner, Hans-Peter Dienes, Danijel Kivaranovic, Christian Schachner, Markus Zeitlinger, Beatrix Wulkersdorfer, Peter Rauch, Gerhard Prager, Michael Trauner, Wolfgang Mikulits. The non-invasive serum biomarker soluble Axl accurately detects advanced liver fibrosis and cirrhosis. Cell Death & Disease 2017; 8(10): e3135 doi: 10.1038/cddis.2017.554
|
| 90 |
Zeinab Anwar ElKabbany, Eman Abdel Rahman Ismail, Eman Tawfik Hamed, Nancy Samir Elbarbary. The impact of vildagliptin as an add‐on therapy on matrix metalloproteinase‐14 levels, liver stiffness and subclinical atherosclerosis in adolescents with type 1 diabetes and non‐alcoholic steatohepatitis: A randomized controlled trial. Diabetes, Obesity and Metabolism 2024; 26(12): 5857 doi: 10.1111/dom.15958
|
| 91 |
Sumitro Kosasih, Wong Zhi Qin, Rafiz Abdul Rani, Nazefah Abd Hamid, Ngiu Chai Soon, Shamsul Azhar Shah, Yazmin Yaakob, Raja Affendi Raja Ali. Relationship between Serum Cytokeratin-18, Control Attenuation Parameter, NAFLD Fibrosis Score, and Liver Steatosis in Nonalcoholic Fatty Liver Disease. International Journal of Hepatology 2018; 2018: 1 doi: 10.1155/2018/9252536
|
| 92 |
Chetan Mandelia, Mohammad Nasser Kabbany, Sarah Worley, Praveen Kumar Conjeevaram Selvakumar. Performance Characteristics, Intra‐ and Inter‐operator Agreement of Transient Elastography in Pediatric Nonalcoholic Fatty Liver Disease. Journal of Pediatric Gastroenterology and Nutrition 2021; 72(3): 430 doi: 10.1097/MPG.0000000000002991
|
| 93 |
Tinsay A. Woreta, Mark L. Van Natta, Mariana Lazo, Arunkumar Krishnan, Brent A. Neuschwander-Tetri, Rohit Loomba, Anna Mae Diehl, Manal F. Abdelmalek, Naga Chalasani, Samer Gawrieh, Srinivasan Dasarathy, Raj Vuppalanchi, Mohammad S. Siddiqui, Kris V. Kowdley, Arthur McCullough, Norah A. Terrault, Cynthia Behling, David E. Kleiner, Mark Fishbein, Paula Hertel, Laura A. Wilson, Emily P. Mitchell, Laura A. Miriel, Jeanne M. Clark, James Tonascia, Arun J. Sanyal, Pavel Strnad. Validation of the accuracy of the FAST™ score for detecting patients with at-risk nonalcoholic steatohepatitis (NASH) in a North American cohort and comparison to other non-invasive algorithms. PLOS ONE 2022; 17(4): e0266859 doi: 10.1371/journal.pone.0266859
|
| 94 |
Hanying Liu, Xiao Li, Xiaodong Han, Yan Zhang, Yanting Gu, Lianjie Sun, Junfeng Han, Yinfang Tu, Yuqian Bao, Wenkun Bai, Haoyong Yu. Simple surrogate equations to predict controlled attenuation parameter values for screening non-alcoholic fatty liver disease in a Chinese population. Frontiers in Medicine 2022; 9 doi: 10.3389/fmed.2022.894895
|
| 95 |
Zeinab Anwar Elkabany, Rasha Tarif Hamza, Eman Abdel Rahman Ismail, Aisha Elsharkawy, Ayman Yosry, Sherief Musa, Marwa Ahmad Khalaf, Roba Maher Elgawesh, Gamal Esmat. Serum visfatin level as a noninvasive marker for nonalcoholic fatty liver disease in children and adolescents with obesity: relation to transient elastography with controlled attenuation parameter. European Journal of Gastroenterology & Hepatology 2020; 32(8): 1008 doi: 10.1097/MEG.0000000000001608
|
| 96 |
Francesco Andreozzi, Elettra Mancuso, Elisa Mazza, Gaia Chiara Mannino, Teresa Vanessa Fiorentino, Franco Arturi, Elena Succurro, Maria Perticone, Angela Sciacqua, Tiziana Montalcini, Arturo Pujia, Giorgio Sesti. One‐hour post‐load glucose levels are associated with hepatic steatosis assessed by transient elastography. Diabetes, Obesity and Metabolism 2024; 26(2): 682 doi: 10.1111/dom.15358
|
| 97 |
Nicha Teeratorn, Panida Piyachaturawat, Kessarin Thanapirom, Roongruedee Chaiteerakij, Kanokwan Sonsiri, Piyawat Komolmit, Pisit Tangkijvanich, Rungsun Rerknimitr, Leon Adams, Sombat Treeprasertsuk. Screening for non‐alcoholic fatty liver disease in community setting: A cohort study using controlled attenuation parameter‐transient elastography. JGH Open 2020; 4(2): 245 doi: 10.1002/jgh3.12252
|
| 98 |
Kanako Kato, Kunihiro Suzuki, Chie Aoki, Masaaki Sagara, Takafumi Niitani, Sho Wakamatsu, Kazunori Yanagi, Yoshimasa Aso. The effects of intermittent use of the SGLT-2 inhibitor, dapagliflozin, in overweight patients with type 2 diabetes in Japan: a randomized, crossover, controlled clinical trial. Expert Opinion on Pharmacotherapy 2017; 18(8): 743 doi: 10.1080/14656566.2017.1317748
|
| 99 |
Yuan Li, Shousheng Liu, Yuqiang Gao, Huan Ma, Shuhui Zhan, Yan Yang, Yongning Xin, Shiying Xuan. Association of TM6SF2 rs58542926 gene polymorphism with the risk of non-alcoholic fatty liver disease and colorectal adenoma in Chinese Han population. BMC Biochemistry 2019; 20(1) doi: 10.1186/s12858-019-0106-3
|
| 100 |
Alejandro Campos-Murguía, Astrid Ruiz-Margáin, José A González-Regueiro, Ricardo U Macías-Rodríguez. Clinical assessment and management of liver fibrosis in non-alcoholic fatty liver disease. World Journal of Gastroenterology 2020; 26(39): 5919-5943 doi: 10.3748/wjg.v26.i39.5919
|
| 101 |
Michael H. Le, Linda Henry, Ramsey Cheung, Mindie H. Nguyen. Transient Elastography and Serum-Based Tests for Diagnosis of Fatty Liver and Advanced Fibrosis in a Community Cohort: A Cross-Sectional Analysis. Digestive Diseases 2023; 41(5): 767 doi: 10.1159/000526503
|
| 102 |
Yue-Yan Hu, Ning-Ling Dong, Qiu Qu, Xu-Fan Zhao, Hong-Ju Yang. The correlation between controlled attenuation parameter and metabolic syndrome and its components in middle-aged and elderly nonalcoholic fatty liver disease patients. Medicine 2018; 97(43): e12931 doi: 10.1097/MD.0000000000012931
|
| 103 |
Min-Kyeong Kim, Heon-Ju Kwon, Kangsu Shin, Hyosoon Park, Hee-Yeon Woo, Chang-Hun Park, Min-Jung Kwon. Liver Fibrosis Biomarker Validation Using Machine Learning Algorithms. Laboratory Medicine Online 2023; 13(3): 189 doi: 10.47429/lmo.2023.13.3.189
|
| 104 |
Celso Nilo Didoné Filho, Cleiton Jonei Reginatto, Cláudia Alexandra Pontes Ivantes, Rodrigo Strobel, Ana Paula Percicote, Marcio Petenusso, Cicero Jordan R. Sobreira da Silva, Cicero Jonas R. Benjamim, Rosana Bento Radominski. Comparison between non-invasive methods and liver histology to stratify liver fibrosis in obese patients submitted to bariatric surgery. Obesity Research & Clinical Practice 2021; 15(2): 152 doi: 10.1016/j.orcp.2021.02.004
|
| 105 |
Nobuharu Tamaki, Yohei Koizumi, Masashi Hirooka, Norihisa Yada, Hitomi Takada, Osamu Nakashima, Masatoshi Kudo, Yoichi Hiasa, Namiki Izumi. Novel quantitative assessment system of liver steatosis using a newly developed attenuation measurement method. Hepatology Research 2018; 48(10): 821 doi: 10.1111/hepr.13179
|
| 106 |
Laura Martínez‐Arenas, Carmen Vinaixa, Isabel Conde, Sara Lorente, Fernando Díaz‐Fontenla, Patrice Marques, Judith Pérez‐Rojas, Eva Montalvá, Ângela Carvalho‐Gomes, Marina Berenguer. FibroScan compared to liver biopsy for accurately staging recurrent hepatic steatosis and fibrosis after transplantation for MASH. Liver International 2024; doi: 10.1111/liv.16085
|
| 107 |
Bei Gao, Atoosa Emami, Rongrong Zhou, Sonja Lang, Yi Duan, Yanhan Wang, Lu Jiang, Rohit Loomba, David A. Brenner, Peter Stärkel, Bernd Schnabl. Functional Microbial Responses to Alcohol Abstinence in Patients With Alcohol Use Disorder. Frontiers in Physiology 2020; 11 doi: 10.3389/fphys.2020.00370
|
| 108 |
Farrah Naz Hussain, Emma Rosenbluth, Kristina Martimucci Feldman, Tirtza Spiegel Strauss, Emily Schneider, Emily Schmidt-Beauchat, Clara Rodriguez-Rivas, Lois Brustman, Tatyana Kushner. Transient elastography and controlled attenuation parameter to evaluate hepatic steatosis and liver stiffness in postpartum patients. The Journal of Maternal-Fetal & Neonatal Medicine 2023; 36(1) doi: 10.1080/14767058.2023.2190838
|
| 109 |
Joris T. Hepkema, Floris B. Poelmann, Annette S.H. Gouw, Robbert J. de Haas, Evelien W. Duiker, Hans Blokzijl, Joost M. Klaase. Malignant Transformation of an HNF1a-Inactivated Hepatocellular Adenoma to Hepatocellular Carcinoma. Case Reports in Gastroenterology 2020; 14(3): 577 doi: 10.1159/000510215
|
| 110 |
Lucija Ruzman, Ivana Mikolasevic, Kristina Baraba Dekanic, Sandra Milic, Goran Palcevski. Advances in diagnosis of chronic liver diseases in pediatric patients. World Journal of Pediatrics 2018; 14(6): 541 doi: 10.1007/s12519-018-0197-8
|
| 111 |
Julia Y. Payne, Naim Alkhouri, Phuc Le, Michael B. Rothberg, Prido Polanco, Celine Sakkal, Srinivasan Dasarathy. Prevalence of at-risk NASH and its association with metabolic syndrome in US adults with NAFLD, 2017–2018. Hepatology Communications 2023; 7(1): e0019 doi: 10.1097/HC9.0000000000000019
|
| 112 |
Andrea de Diego-Sola, Agustín Castiella Eguzkiza, Luis María López Domínguez, Iratxe Urreta Barallobre, María José Sánchez Iturri, Joaquín María Belzunegui Otaño, Eva María Zapata Morcillo, Andrea de Diego-Sola, Agustin Castiella Eguzkiza, Luis María López Domínguez, Iratxe Urreta Barallobre, María José Sánchez Iturri, Cesar Antonio Egües Dubuc, Jorge Jesús Cancio Fanlo, Olga Maíz Alonso, Jesús Alejandro Valero Jaimes, María Vaamonde Lorenzo, Leire Samaniego Leoz, Joaquín Belzunegui Otaño, Eva María Zapata Morcillo. Assessment of liver fibrosis in patients with rheumatoid arthritis treated with methotrexate: Utility of fibroscan and biochemical markers in routine clinical practice. Reumatología Clínica (English Edition) 2023; 19(8): 412 doi: 10.1016/j.reumae.2022.12.002
|
| 113 |
Nutthachoke Mahachai, Chaiwat Washirasaksiri, Pinyapat Ariyakunaphan, Chayanis Kositamongkol, Tullaya Sitasuwan, Rungsima Tinmanee, Chonticha Auesomwang, Naruemit Sayabovorn, Thanet Chaisathaphol, Pochamana Phisalprapa, Phunchai Charatcharoenwitthaya, Weerachai Srivanichakorn. Clinical Predictive Score for Identifying Metabolic Dysfunction-Associated Steatotic Liver Disease in Individuals with Prediabetes Using Transient Elastography. Journal of Clinical Medicine 2023; 12(24): 7617 doi: 10.3390/jcm12247617
|
| 114 |
Marilena DURAZZO, Letizia MARZARI, Silvia BONETTO, Arianna FERRO, Maria C. GHIGO, Paola BELCI, Alessandro COLLO, Sharmila FAGOONEE. Noninvasive diagnosis of fibrosis in non-alcoholic fatty liver disease: diagnostic accuracy of different scores. Minerva Gastroenterologica e Dietologica 2021; 66(4) doi: 10.23736/S1121-421X.20.02753-1
|
| 115 |
Lin Yang, Yafei Zhu, Lu Zhou, Huimei Yin, Yan Lin, Guangsheng Wu. Transient Elastography in the Diagnosis of Pediatric Non-alcoholic Fatty Liver Disease and Its Subtypes. Frontiers in Pediatrics 2022; 10 doi: 10.3389/fped.2022.808997
|
| 116 |
Hongye Peng, Liang Pan, Simiao Ran, Miyuan Wang, Shuxia Huang, Mo Zhao, Zhengmin Cao, Ziang Yao, Lei Xu, Qing Yang, Wenliang Lv. Prediction of MAFLD and NAFLD using different screening indexes: A cross-sectional study in U.S. adults. Frontiers in Endocrinology 2023; 14 doi: 10.3389/fendo.2023.1083032
|
| 117 |
Andy McKay, Carlos Pantoja, Richard Hall, Sarah Matthews, Phil Spalding, Rajarshi Banerjee. Patient understanding and experience of non-invasive imaging diagnostic techniques and the liver patient pathway. Journal of Patient-Reported Outcomes 2021; 5(1) doi: 10.1186/s41687-021-00363-5
|
| 118 |
Omesh Goyal, Sahil Nohria, Prerna Goyal, Jaskirat Kaur, Sarit Sharma, Ajit Sood, Rajoo Singh Chhina. Saroglitazar in patients with non-alcoholic fatty liver disease and diabetic dyslipidemia: a prospective, observational, real world study. Scientific Reports 2020; 10(1) doi: 10.1038/s41598-020-78342-x
|
| 119 |
Sebastian Zenovia, Cristina Muzica, Mihaela Dimache. Essentials of Non-Alcoholic Fatty Liver Disease. 2023; : 107 doi: 10.1007/978-3-031-33548-8_10
|
| 120 |
Cátia Arieira, Sara Monteiro, Sofia Xavier, Francisca Dias de Castro, Joana Magalhães, Maria J. Moreira, Carla Marinho, José Cotter. Hepatic steatosis and patients with inflammatory bowel disease: when transient elastography makes the difference. European Journal of Gastroenterology & Hepatology 2019; 31(8): 998 doi: 10.1097/MEG.0000000000001319
|
| 121 |
Kristin E. Morrill, Victoria L. Bland, Yann C. Klimentidis, Melanie D. Hingle, Cynthia A. Thomson, David O. Garcia. Assessing Interactions between PNPLA3 and Dietary Intake on Liver Steatosis in Mexican-Origin Adults. International Journal of Environmental Research and Public Health 2021; 18(13): 7055 doi: 10.3390/ijerph18137055
|
| 122 |
Peter Lemmer, Lydia Christina Rohr, Marie Henning, Kerem Bulut, Paul Manka, Ali Canbay, Jan-Peter Sowa. Liver Stiffness Determined by Transient Elastography Is a Simple and Highly Accurate Predictor for Presence of Liver Cirrhosis in Clinical Routine. Digestive Diseases 2024; 42(3): 265 doi: 10.1159/000538426
|
| 123 |
Yuanhui Guo, Baixuan Shen, Yanli Xue, Ying Li. Development and validation of a non-invasive model for predicting significant fibrosis based on patients with nonalcoholic fatty liver disease in the United States. Frontiers in Endocrinology 2023; 14 doi: 10.3389/fendo.2023.1207365
|
| 124 |
Ivana Mikolasevic, Viktor Domislovic, Mia Klapan, Toni Juric, Andjela Lukic, Irena Krznaric-Zrnic, Dora Fuckar-Cupic, Davor Stimac, Tajana Filipec Kanizaj, Zeljko Krznaric, Delfa Radic-Kristo, Sandra Milic, Marko Martinovic, Aron Grubesic, Ivica Grgurevic. Accuracy of Controlled Attenuation Parameter and Liver Stiffness Measurement in Patients with Non-alcoholic Fatty Liver Disease. Ultrasound in Medicine & Biology 2021; 47(3): 428 doi: 10.1016/j.ultrasmedbio.2020.11.015
|
| 125 |
Stergios Kechagias, Mattias Ekstedt, Christian Simonsson, Patrik Nasr. Non-invasive diagnosis and staging of non-alcoholic fatty liver disease. Hormones 2022; 21(3): 349 doi: 10.1007/s42000-022-00377-8
|
| 126 |
Chetan Mandelia, Mohammad Nasser Kabbany, Praveen Kumar Conjeevaram Selvakumar, Naim Alkhouri. The Search for Noninvasive Methods to Identify Liver Fibrosis in Children With Nonalcoholic Fatty Liver Disease. Biomarkers in Medicine 2018; 12(3): 265 doi: 10.2217/bmm-2017-0038
|
| 127 |
Ya-Ju Chan, Shy-Shin Chang, Jenny L. Wu, Sen-Te Wang, Cheng-Sheng Yu. Association between liver stiffness measurement by transient elastography and chronic kidney disease. Medicine 2022; 101(4): e28658 doi: 10.1097/MD.0000000000028658
|
| 128 |
Sapwarobol Suwimol, Tangkijvanich Pisit, Avihingsanon Anchalee, Kongruttanachok Narisorn, Jantarapakde Jureeporn, Jiamjarasrangsi Wiroj, Michael W. Greene. Neck circumference as a screening measure for identifying NAFLD among a group of academic employees in Bangkok, Thailand. PLOS ONE 2022; 17(2): e0263826 doi: 10.1371/journal.pone.0263826
|
| 129 |
EASL-EASD-EASO Clinical Practice Guidelines on the Management of Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD). Obesity Facts 2024; 17(4): 374 doi: 10.1159/000539371
|
| 130 |
Shoukat Ali Samejo, Zaigham Abbas, Muhammad Asim. Effects of anthropometric and metabolic parameters on transaminase levels and liver stiffness in patients with non-alcohol fatty liver disease. Tropical Doctor 2021; 51(2): 185 doi: 10.1177/0049475520962742
|
| 131 |
Seung Joon Choi, Seong Min Kim, Yun Soo Kim, Oh Sang Kwon, Seung Kak Shin, Kyoung Kon Kim, Kiyoung Lee, Ie Byung Park, Cheol Soo Choi, Dong Hae Chung, Jaehun Jung, MunYoung Paek, Dae Ho Lee. Magnetic Resonance-Based Assessments Better Capture Pathophysiologic Profiles and Progression in Nonalcoholic Fatty Liver Disease. Diabetes & Metabolism Journal 2021; 45(5): 739 doi: 10.4093/dmj.2020.0137
|
| 132 |
Samantha Maurotti, Roberta Pujia, Elisa Mazza, Maria Francesca Pileggi, Franco Arturi, Maria Grazia Tarsitano, Tiziana Montalcini, Arturo Pujia, Yvelise Ferro. Low Relative Handgrip Strength Is Associated with a High Risk of Non-Alcoholic Fatty Liver Disease in Italian Adults: A Retrospective Cohort Study. Applied Sciences 2023; 13(22): 12489 doi: 10.3390/app132212489
|
| 133 |
Paula Cenira Senger de CASTRO, Helen Caroline Perussolo ALBERTON, Maria Lucia Alves PEDROSO, Daphne Benatti Gonçalves MORSOLETTO, Alcindo PISSAIA JUNIOR, Cláudia Alexandra Pontes IVANTES. EVALUATION OF PROGRESSION OF HEPATIC FIBROSIS IN A GROUP OF PATIENTS WITH NON-ALCOHOLIC FATTY LIVER DISEASE ACCOMPANIED FOR 10 YEARS. Arquivos de Gastroenterologia 2019; 56(3): 256 doi: 10.1590/s0004-2803.201900000-48
|
| 134 |
Carlo Smirne, Violante Mulas, Matteo Nazzareno Barbaglia, Venkata Ramana Mallela, Rosalba Minisini, Nadia Barizzone, Michela Emma Burlone, Mario Pirisi, Elena Grossini. Periostin Circulating Levels and Genetic Variants in Patients with Non-Alcoholic Fatty Liver Disease. Diagnostics 2020; 10(12): 1003 doi: 10.3390/diagnostics10121003
|
| 135 |
Ji Yeon Seo, Eun Ju Cho, Min Joo Kim, Min‐Sun Kwak, Jong In Yang, Su Jin Chung, Jeong Yoon Yim, Ji Won Yoon, Goh Eun Chung. The relationship between metabolic dysfunction‐associated fatty liver disease and low muscle mass in an asymptomatic Korean population. Journal of Cachexia, Sarcopenia and Muscle 2022; 13(6): 2953 doi: 10.1002/jcsm.13099
|
| 136 |
Kyungsun Han, Ojin Kwon, Hyo-ju Park, So-Young Jung, Changsop Yang, Chang-Gue Son. Effect of Daesiho-tang on obesity with non-alcoholic fatty liver disease: a study protocol for a randomised, double-blind, placebo-controlled pilot trial. Trials 2020; 21(1) doi: 10.1186/s13063-020-4068-y
|
| 137 |
Sanju Kumari, Mini George. Diagnostic Accuracy of a Nurse-Led Transient Elastography. Gastroenterology Nursing 2023; 46(2): 118 doi: 10.1097/SGA.0000000000000707
|
| 138 |
Ying-ying Yu, Yu-ling Tong, Ling-yan Wu, Xin-yan Yu. Helicobacter pylori infection eradication for nonalcoholic fatty liver disease: a randomized controlled trial. Scientific Reports 2022; 12(1) doi: 10.1038/s41598-022-23746-0
|
| 139 |
Luiz F. Viola, Cynthia M. Valerio, João M. Araujo-Neto, Fabio F. Santos, Felipe Matsuura, Rodrigo O. Moreira, Amélio F. Godoy-Matos. Waist circumference is independently associated with liver steatosis and fibrosis in LMNA-related and unrelated Familial Partial Lipodystrophy women. Diabetology & Metabolic Syndrome 2023; 15(1) doi: 10.1186/s13098-023-01156-0
|
| 140 |
Joana Rigor, Andreia Diegues, José Presa, Pedro Barata, Daniela Martins-Mendes. Noninvasive fibrosis tools in NAFLD: validation of APRI, BARD, FIB-4, NAFLD fibrosis score, and Hepamet fibrosis score in a Portuguese population. Postgraduate Medicine 2022; 134(4): 435 doi: 10.1080/00325481.2022.2058285
|
| 141 |
Frank Tacke, Paul Horn, Vincent Wai-Sun Wong, Vlad Ratziu, Elisabetta Bugianesi, Sven Francque, Shira Zelber-Sagi, Luca Valenti, Michael Roden, Fritz Schick, Hannele Yki-Järvinen, Amalia Gastaldelli, Roberto Vettor, Gema Frühbeck, Dror Dicker. EASL–EASD–EASO Clinical Practice Guidelines on the management of metabolic dysfunction-associated steatotic liver disease (MASLD). Journal of Hepatology 2024; 81(3): 492 doi: 10.1016/j.jhep.2024.04.031
|
| 142 |
FaisalA Alsaif, SaraH Alqahtani, AmaniM Alsadoon, KhalidA Alswat, AymanA Abdo, MazenM Hassanain, AbdulsalamB Alsharabi, GhadeerR Aljuhani, HishamM Alkhalidi, MohammadS Elsharkawy, MaramA Alotaibi, FaisalM Sanai, WaleedK Al-hamoudi. Prevalence of biopsy-proven nonalcoholic fatty liver among patients with gallstone disease. Saudi Journal of Gastroenterology 2020; 26(4): 204 doi: 10.4103/sjg.SJG_29_20
|
| 143 |
Luis Chi-Cervera, Gordon Montalvo, María Icaza-Chávez, Julio Torres-Romero, Víctor Arana-Argáez, Mario Ramírez-Camacho, Julio Lara-Riegos. Clinical relevance of lipid panel and aminotransferases in the context of hepatic steatosis and fibrosis as measured by transient elastography (FibroScan®). Journal of Medical Biochemistry 2021; 40(1): 60 doi: 10.5937/jomb0-24689
|
| 144 |
Leila Kamali, Atoosa Adibi, Shadi Ebrahimian, Fahime Jafari, Mohsen Sharifi. Diagnostic Performance of Ultrasonography in Detecting Fatty Liver Disease in Comparison with Fibroscan in People Suspected of Fatty Liver. Advanced Biomedical Research 2019; 8(1): 69 doi: 10.4103/abr.abr_114_19
|
| 145 |
Joshua Trowell, Joseph Alukal, Talan Zhang, Li Liu, Anurag Maheshwari, Hwan Y. Yoo, Paul J. Thuluvath. How Good Are Controlled Attenuation Parameter Scores from Fibroscan to Assess Steatosis, NASH, and Fibrosis?. Digestive Diseases and Sciences 2021; 66(4): 1297 doi: 10.1007/s10620-020-06269-4
|
| 146 |
Rohit Loomba, Anjali Jain, Anna Mae Diehl, Cynthia D. Guy, Dana Portenier, Ranjan Sudan, Seema Singh, Claire Faulkner, Lisa Richards, Kelly D. Hester, Lauren Okada, Xiao-jun Li, Larry Mimms, Manal F. Abdelmalek. Validation of Serum Test for Advanced Liver Fibrosis in Patients With Nonalcoholic Steatohepatitis. Clinical Gastroenterology and Hepatology 2019; 17(9): 1867 doi: 10.1016/j.cgh.2018.11.004
|
| 147 |
Young-Kyu Kim, Oh-Sung Kwon, Kyu Hee Her. The grade of nonalcoholic fatty liver disease is an independent risk factor for gallstone disease. Medicine 2019; 98(27): e16018 doi: 10.1097/MD.0000000000016018
|
| 148 |
Nicola Pugliese, Ludovico Alfarone, Ivan Arcari, Silvia Giugliano, Tommaso Lorenzo Parigi, Maria Rescigno, Ana Lleo, Alessio Aghemo. Clinical features and management issues of NAFLD-related HCC: what we know so far. Expert Review of Gastroenterology & Hepatology 2023; 17(1): 31 doi: 10.1080/17474124.2023.2162503
|
| 149 |
Melissa Lopez-Pentecost, Martha Tamez, Josiemer Mattei, Elizabeth T. Jacobs, Cynthia A. Thomson, David O. Garcia. Adherence to a Traditional Mexican Diet Is Associated with Lower Hepatic Steatosis in US-Born Hispanics of Mexican Descent with Overweight or Obesity. Nutrients 2023; 15(23): 4997 doi: 10.3390/nu15234997
|
| 150 |
Anna E. Ferguson, Stavra A. Xanthakos, Robert M. Siegel. Challenges in Screening for Pediatric Nonalcoholic Fatty Liver Disease. Clinical Pediatrics 2018; 57(5): 558 doi: 10.1177/0009922817733300
|
| 151 |
Qun-Yan Yao, Ya-Dong Feng, Pei Han, Feng Yang, Guang-Qi Song. Hepatic microenvironment underlies fibrosis in chronic hepatitis B patients. World Journal of Gastroenterology 2020; 26(27): 3917-3928 doi: 10.3748/wjg.v26.i27.3917
|
| 152 |
Tanawat Jongraksak, Abhasnee Sobhonslidsuk, Janjira Jatchavala, Daruneewan Warodomwichit, Piyaporn Kaewduang, Somnuek Sungkanuparph. Prevalence and predicting factors of metabolic-associated fatty liver disease diagnosed by transient elastography with controlled attenuation parameters in HIV-positive people. International Journal of STD & AIDS 2021; 32(3): 266 doi: 10.1177/0956462420960997
|
| 153 |
Andrea de Diego-Sola, Agustín Castiella Eguzkiza, Luis María López Domínguez, Iratxe Urreta Barallobre, María José Sánchez Iturri, Joaquín María Belzunegui Otaño, Eva María Zapata Morcillo, Andrea de Diego-Sola, Agustin Castiella Eguzkiza, Luis María López Domínguez, Iratxe Urreta Barallobre, María José Sánchez Iturri, Cesar Antonio Egües Dubuc, Jorge Jesús Cancio Fanlo, Olga Maíz Alonso, Jesús Alejandro Valero Jaimes, María Vaamonde Lorenzo, Leire Samaniego Leoz, Joaquín Belzunegui Otaño, Eva María Zapata Morcillo. Assessment of liver fibrosis in patients with rheumatoid arthritis treated with methotrexate: Utility of fibroscan and biochemical markers in routine clinical practice. Reumatología Clínica 2023; 19(8): 412 doi: 10.1016/j.reuma.2022.12.003
|
| 154 |
Min‐Sun Kwak, Goh Eun Chung, Jong In Yang, Jeong Yoon Yim, Su Jin Chung, Se Young Jung, Joo Sung Kim. Clinical implications of controlled attenuation parameter in a health check‐up cohort. Liver International 2018; 38(5): 915 doi: 10.1111/liv.13558
|
| 155 |
Paul Manka, Amos Zeller, Wing-Kin Syn. Fibrosis in Chronic Liver Disease: An Update on Diagnostic and Treatment Modalities. Drugs 2019; 79(9): 903 doi: 10.1007/s40265-019-01126-9
|
| 156 |
Dorotea Bozic, Kristian Podrug, Ivana Mikolasevic, Ivica Grgurevic. Ultrasound Methods for the Assessment of Liver Steatosis: A Critical Appraisal. Diagnostics 2022; 12(10): 2287 doi: 10.3390/diagnostics12102287
|
| 157 |
Matthias Buechter, Guido Gerken. Liver Function—How to Screen and to Diagnose: Insights from Personal Experiences, Controlled Clinical Studies and Future Perspectives. Journal of Personalized Medicine 2022; 12(10): 1657 doi: 10.3390/jpm12101657
|
| 158 |
Nicolás Salva-Pastor, Norberto C. Chávez-Tapia, Misael Uribe, Natalia Nuño-Lámbarri. Understanding the association of polycystic ovary syndrome and non-alcoholic fatty liver disease. The Journal of Steroid Biochemistry and Molecular Biology 2019; 194: 105445 doi: 10.1016/j.jsbmb.2019.105445
|
| 159 |
Marilena DURAZZO, Arianna FERRO. Novelties on non-invasive scores for the assessment of liver steatosis. Minerva Gastroenterology 2023; 69(2) doi: 10.23736/S2724-5985.22.03210-7
|
| 160 |
Mohammadjavad Sotoudeheian. Agile 3+ and Metabolic Dysfunction-Associated Fatty Liver Disease:
Detecting Advanced Fibrosis based on Reported Liver Stiffness
Measurement in FibroScan and Laboratory Findings. The International Journal of Gastroenterology and Hepatology Diseases 2024; 3 doi: 10.2174/0126662906302851240604042954
|
| 161 |
Gordon P. Watt, Isela De La Cerda, Jen‐Jung Pan, Michael B. Fallon, Laura Beretta, Rohit Loomba, Miryoung Lee, Joseph B. McCormick, Susan P. Fisher‐Hoch. Elevated Glycated Hemoglobin Is Associated With Liver Fibrosis, as Assessed by Elastography, in a Population‐Based Study of Mexican Americans. Hepatology Communications 2020; 4(12): 1793 doi: 10.1002/hep4.1603
|
| 162 |
Xiao Li, Ziwei Sun, Wei Liu, Lianjie Sun, Junyi Ren, Ying Xu, Haoyong Yu, Wenkun Bai. Methodology exploration and reproducibility evaluation of TAI and TSI for quantitative ultrasound assessment of hepatic steatosis. Heliyon 2024; 10(11): e31904 doi: 10.1016/j.heliyon.2024.e31904
|
| 163 |
Antonella Mirizzi, Isabella Franco, Carla Maria Leone, Caterina Bonfiglio, Raffaele Cozzolongo, Maria Notarnicola, Vito Giannuzzi, Valeria Tutino, Valentina De Nunzio, Irene Bruno, Claudia Buongiorno, Angelo Campanella, Valentina Deflorio, Annamaria Pascale, Filippo Procino, Paolo Sorino, Alberto Rubén Osella. Effects of Some Food Components on Non-Alcoholic Fatty Liver Disease Severity: Results from a Cross-Sectional Study. Nutrients 2019; 11(11): 2744 doi: 10.3390/nu11112744
|
| 164 |
Maneerat Chayanupatkul, Divya B. Dasani, Kristian Sogaard, Thomas D. Schiano. The Utility of Assessing Liver Allograft Fibrosis and Steatosis Post–Liver Transplantation Using Transient Elastography With Controlled Attenuation Parameter. Transplantation Proceedings 2021; 53(1): 159 doi: 10.1016/j.transproceed.2020.02.160
|
| 165 |
Willy Theel, Bianca M. Boxma‐de Klerk, Femme Dirksmeier‐Harinck, Elisabeth F. C. van Rossum, Danny A. Kanhai, Jan Apers, Bas M. van Dalen, Robert J. de Knegt, Adriaan G. Holleboom, Maarten E. Tushuizen, Diederick E. Grobbee, Janneke Wiebolt, Manuel Castro Cabezas. Evaluation of nonalcoholic fatty liver disease (NAFLD) in severe obesity using noninvasive tests and imaging techniques. Obesity Reviews 2022; 23(8) doi: 10.1111/obr.13481
|
| 166 |
Zahra Dehnavi, Farkhonde Razmpour, Mahmoud Belghaisi Naseri, Mohsen Nematy, Seyed Ali Alamdaran, Hassan Ali Vatanparast, Mohsen Azimi Nezhad, Bita Abbasi, Azita Ganji. Fatty Liver Index (FLI) in Predicting Non-alcoholic Fatty Liver Disease (NAFLD). Hepatitis Monthly 2018; 18(2) doi: 10.5812/hepatmon.63227
|
| 167 |
Audrey Kovatsch, Hanna Honcharova‐Biletska, Daniel Segna, Klaus Steigmiller, Sena Blümel, Rudolf A. Deibel, Tobias Kühlewindt, Georg Leinenkugel, Sandra Müller, Eva Furrer, Khoschy Schawkat, Cäcilia S. Reiner, Achim Weber, Beat Müllhaupt, Michael Scharl, Christoph Gubler, Christoph Jüngst. Performance of two‐dimensional shear wave elastography and transient elastography compared to liver biopsy for staging of liver fibrosis. European Journal of Clinical Investigation 2023; 53(7) doi: 10.1111/eci.13980
|
| 168 |
Isabella Angeli-Pahim, Anastasia Chambers, Sergio Duarte, Ali Zarrinpar. Current Trends in Surgical Management of Hepatocellular Carcinoma. Cancers 2023; 15(22): 5378 doi: 10.3390/cancers15225378
|
| 169 |
Duck Min Seo, Sang Min Lee, Ji Won Park, Min-Jeong Kim, Hong Il Ha, Sun-Young Park, Kwanseop Lee. How many times should we repeat measurements of the ultrasound-guided attenuation parameter for evaluating hepatic steatosis?. Ultrasonography 2023; 42(2): 227 doi: 10.14366/usg.22122
|
| 170 |
Paul R Armstrong, Éidín Ní Shé. Creating a framework for an integrated novel ultrasound clinic for metabolic dysfunction-associated steatotic liver disease. British Journal of Healthcare Management 2024; 30(6): 1 doi: 10.12968/bjhc.2023.0037
|
| 171 |
Samira Saghafi, Elham Chamani, Fatemeh Salmani, Reza Fadaei, Efat Shafiei, Nariman Moradi, Tahmine Tavakoli. Genetic predisposition to nonalcoholic fatty liver disease: insights from ANGPTL8 gene variants in Iranian adults. Lipids in Health and Disease 2023; 22(1) doi: 10.1186/s12944-023-01905-0
|
| 172 |
Somaya Albhaisi, Abhijit Chowdhury, Arun J. Sanyal. Non-alcoholic fatty liver disease in lean individuals. JHEP Reports 2019; 1(4): 329 doi: 10.1016/j.jhepr.2019.08.002
|
| 173 |
Yujuan Zhang, Liulan Xiang, Fang Qi, Yutian Cao, Wenhui Zhang, Tiansu Lv, Xiqiao Zhou. The metabolic profiles and body composition of non-obese metabolic associated fatty liver disease. Frontiers in Endocrinology 2024; 15 doi: 10.3389/fendo.2024.1322563
|
| 174 |
Thomas G. Cotter, Mary Rinella. Nonalcoholic Fatty Liver Disease 2020: The State of the Disease. Gastroenterology 2020; 158(7): 1851 doi: 10.1053/j.gastro.2020.01.052
|
| 175 |
Jonathan Mertens, Luc F. Van Gaal, Sven M. Francque, Christophe De Block. NAFLD in type 1 diabetes: overrated or underappreciated?. Therapeutic Advances in Endocrinology and Metabolism 2021; 12 doi: 10.1177/20420188211055557
|
| 176 |
Ivana Mikolasevic, Sanja Stojsavljevic, Filip Blazic, Maja Mijic, Delfa Radic-Kristo, Toni Juric, Nadija Skenderevic, Mia Klapan, Andjela Lukic, Tajana Filipec Kanizaj. Noninvasive markers of liver steatosis and fibrosis after liver transplantation – Where do we stand?. World Journal of Transplantation 2021; 11(3): 37-53 doi: 10.5500/wjt.v11.i3.37
|
| 177 |
A. Mantovani, T. Turino, M.G. Lando, K. Gjini, C.D. Byrne, C. Zusi, F. Ravaioli, A. Colecchia, C. Maffeis, G. Salvagno, G. Lippi, E. Bonora, G. Targher. Screening for non-alcoholic fatty liver disease using liver stiffness measurement and its association with chronic kidney disease and cardiovascular complications in patients with type 2 diabetes. Diabetes & Metabolism 2020; 46(4): 296 doi: 10.1016/j.diabet.2019.11.004
|
| 178 |
Vítor Macedo Silva, Marta Freitas, Sofia Xavier, Pedro Boal Carvalho, Joana Magalhães, Carla Marinho, José Cotter. The New FibroScan-AST (FAST) Score: Enhancing Diabetes Mellitus Impact on Metabolic-Associated Fatty Liver Disease. GE - Portuguese Journal of Gastroenterology 2023; 30(6): 422 doi: 10.1159/000527027
|
| 179 |
Mireen Friedrich-Rust, Fabian Schoelzel, Sebastian Maier, Florian Seeger, Julia Rey, Stephan Fichtlscherer, Eva Herrmann, Stefan Zeuzem, Joerg Bojunga, Pavel Strnad. Severity of coronary artery disease is associated with non-alcoholic fatty liver dis-ease: A single-blinded prospective mono-center study. PLOS ONE 2017; 12(10): e0186720 doi: 10.1371/journal.pone.0186720
|
| 180 |
Tülay Çevik Saldiran, Fatma Karantay Mutluay, İlker Yağci, Yusuf Yilmaz. Impact of aerobic training with and without whole-body vibration training on metabolic features and quality of life in non-alcoholic fatty liver disease patients. Annales d'Endocrinologie 2020; 81(5): 493 doi: 10.1016/j.ando.2020.05.003
|
| 181 |
S S Poul, K J Parker. Fat and fibrosis as confounding cofactors in viscoelastic measurements of the liver. Physics in Medicine & Biology 2021; 66(4): 045024 doi: 10.1088/1361-6560/abd593
|
| 182 |
Anirban Sinha, Biswabandhu Bankura. Prevalence of nonalcoholic fatty liver disease in type 2 diabetes mellitus patients from the Eastern region of India. Diabetes Epidemiology and Management 2023; 12: 100161 doi: 10.1016/j.deman.2023.100161
|
| 183 |
Mimi Zhou, Nan Yang, Xin Xing, Danyan Chang, Juan Li, Jiang Deng, Yi Chen, Chunhua Hu, Rou Zhang, Xiaolan Lu, Yingren Zhao, Yingli He. Obesity interacts with hyperuricemia on the severity of non-alcoholic fatty liver disease. BMC Gastroenterology 2021; 21(1) doi: 10.1186/s12876-021-01615-w
|
| 184 |
Yun Kyu Lee, Dong Hyeon Lee, Sae Kyung Joo, Heejoon Jang, Young Ho So, Siwon Jang, Dong Ho Lee, Jeong Hwan Park, Mee Soo Chang, Won Kim. Combi-Elastography versus Transient Elastography for Assessing the Histological Severity of Metabolic Dysfunction-Associated Steatotic Liver Disease. Gut and Liver 2024; 18(6): 1048 doi: 10.5009/gnl240198
|
| 185 |
Dae Ho Lee. Noninvasive Evaluation of Nonalcoholic Fatty Liver Disease. Endocrinology and Metabolism 2020; 35(2): 243 doi: 10.3803/EnM.2020.35.2.243
|
| 186 |
PreyaJanubhai Patel, Fabrina Hossain, Leigh Ula Horsfall, Xuan Banh, Kelly Lee Hayward, Suzanne Williams, Tracey Johnson, Anne Bernard, Nigel Neil Brown, Guy Lampe, Lyndall Buck, Nivene Saad, Anthony William Russell, Patricia Casarolli Valery, Katharine Margaret Irvine, Andrew Donald Clouston, Katherine Anne Stuart, William Rosenberg, Elizabeth Ellen Powell. A Pragmatic Approach Identifies a High Rate of Nonalcoholic Fatty Liver Disease With Advanced Fibrosis in Diabetes Clinics and At‐Risk Populations in Primary Care. Hepatology Communications 2018; 2(8): 897 doi: 10.1002/hep4.1208
|
| 187 |
Alan A Parsa, Katie A Azama, May Vawer, Mel A Ona, Todd B Seto. Prevalence Study of MASLD in Adolescent and Young Adult Pacific Islanders and Asians Living in Hawai’i. Journal of the Endocrine Society 2024; 8(3) doi: 10.1210/jendso/bvad165
|